www.accutarbio.com/accutar-biotechnology-receives-fda-fast-track-designation-for-ac699-in-er-her2-breast-cancer
Preview meta tags from the www.accutarbio.com website.
Linked Hostnames
3General Meta Tags
5- titleAccutar Biotech
- Content-Typetext/html; charset=UTF-8
- viewportwidth=device-width, initial-scale=1
- robotsmax-image-preview:large
- generatorWordPress 6.6.2
Link Tags
15- EditURIhttps://www.accutarbio.com/xmlrpc.php?rsd
- alternatehttps://www.accutarbio.com/wp-json/wp/v2/posts/1415
- alternatehttps://www.accutarbio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.accutarbio.com%2Faccutar-biotechnology-receives-fda-fast-track-designation-for-ac699-in-er-her2-breast-cancer%2F
- alternatehttps://www.accutarbio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.accutarbio.com%2Faccutar-biotechnology-receives-fda-fast-track-designation-for-ac699-in-er-her2-breast-cancer%2F&format=xml
- canonicalhttps://www.accutarbio.com/accutar-biotechnology-receives-fda-fast-track-designation-for-ac699-in-er-her2-breast-cancer/
Links
19- https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.accutarbio.com&esheet=54109082&newsitemid=20240814155176&lan=en-US&anchor=www.accutarbio.com&index=3&md5=8068b2d5857cfcaa6a66a3dc5f09b724
- https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.clinicaltrials.gov&esheet=54109082&newsitemid=20240814155176&lan=en-US&anchor=www.clinicaltrials.gov&index=2&md5=42cb87160f054df90bbe5d744b5f84d5
- https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.fda.gov%2Fpatients%2Ffast-track-breakthrough-therapy-accelerated-approval-priority-review%2Ffast-track&esheet=54109082&newsitemid=20240814155176&lan=en-US&anchor=https%3A%2F%2Fwww.fda.gov%2Fpatients%2Ffast-track-breakthrough-therapy-accelerated-approval-priority-review%2Ffast-track&index=1&md5=0c531125811038e7af481edf5d6bb769
- https://www.accutarbio.com
- https://www.accutarbio.com/about